Search research articles
Contact Us
Filters
Showing results (1-10 of 110) with videos related to
Page
of 11
Sort By:
Acute Cardiac Care
|
April 14, 2010
Bivalirudin during percutaneous coronary interventions in patients with ST segment elevation myocardial infarction
Michael Koutouzis, Per Albertsson
Acta Oncologica (Stockholm, Sweden)
|
October 22, 2008
Low-dose continuous 5-fluorouracil infusion stimulates VEGF-A-mediated angiogenesis
Per Albertsson, Bo Lennernäs, Klas Norrby
Trials
|
September 6, 2014
Coronary angioplasty in octogenarians with emergent coronary syndromes: study protocol for a randomized controlled trial
Berglind Libungan, Geir Hirlekar, Per Albertsson
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
January 11, 2012
Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis
Per Albertsson, Bo Lennernäs, Klas Norrby
Scandinavian Cardiovascular Journal : SCJ
|
June 19, 2004
Survival benefits of CABG and PCI - facts and speculations
Lars Grip, Per Albertsson, Fredrik Scherstén
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
November 25, 2003
Chemotherapy and antiangiogenesis: drug-specific effects on microvessel sprouting
Per Albertsson, Bo Lennernäs, Klas Norrby
Acta Oncologica (Stockholm, Sweden)
|
January 23, 2008
Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by VEGF-A
Per Albertsson, Bo Lennernäs, Klas Norrby
Acta Oncologica (Stockholm, Sweden)
|
March 21, 2006
On metronomic chemotherapy: modulation of angiogenesis mediated by VEGE-A
Per Albertsson, Bo Lennernäs, Klas Norrby
Methods in Molecular Biology (Clifton, N.J.)
|
May 15, 2016
In Vitro Assessment of Human Natural Killer Cell Migration and Invasion
Karin Tomin, Ronald H Goldfarb, Per Albertsson
Oncology Reports
|
October 5, 2007
Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancer
Bo Lennernäs, Per Albertsson, Maliha Edgren, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 110) with videos related to
Sort By:
Page
of 11
Acute Cardiac Care
|
April 14, 2010
Bivalirudin during percutaneous coronary interventions in patients with ST segment elevation myocardial infarction
Michael Koutouzis, Per Albertsson
Acta Oncologica (Stockholm, Sweden)
|
October 22, 2008
Low-dose continuous 5-fluorouracil infusion stimulates VEGF-A-mediated angiogenesis
Per Albertsson, Bo Lennernäs, Klas Norrby
Trials
|
September 6, 2014
Coronary angioplasty in octogenarians with emergent coronary syndromes: study protocol for a randomized controlled trial
Berglind Libungan, Geir Hirlekar, Per Albertsson
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
January 11, 2012
Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis
Per Albertsson, Bo Lennernäs, Klas Norrby
Scandinavian Cardiovascular Journal : SCJ
|
June 19, 2004
Survival benefits of CABG and PCI - facts and speculations
Lars Grip, Per Albertsson, Fredrik Scherstén
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
November 25, 2003
Chemotherapy and antiangiogenesis: drug-specific effects on microvessel sprouting
Per Albertsson, Bo Lennernäs, Klas Norrby
Acta Oncologica (Stockholm, Sweden)
|
January 23, 2008
Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by VEGF-A
Per Albertsson, Bo Lennernäs, Klas Norrby
Acta Oncologica (Stockholm, Sweden)
|
March 21, 2006
On metronomic chemotherapy: modulation of angiogenesis mediated by VEGE-A
Per Albertsson, Bo Lennernäs, Klas Norrby
Methods in Molecular Biology (Clifton, N.J.)
|
May 15, 2016
In Vitro Assessment of Human Natural Killer Cell Migration and Invasion
Karin Tomin, Ronald H Goldfarb, Per Albertsson
Oncology Reports
|
October 5, 2007
Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancer
Bo Lennernäs, Per Albertsson, Maliha Edgren, et al.
Page
of 11